Top Journalists in Chemicals and Pharmaceuticals
Will Beacham ICIS News
Deputy Editor at ICIS News who covers the global chemical industry and hosts/appears on ICIS Think Tank podcasts on market trends and policy impacts. Specialties: Global chemicals markets, Europe chemicals, petrochemicals, industry economics.
Zachary Brennan Endpoints News
Senior editor at Endpoints News focused on FDA, Congress, and the policy forces shaping biopharma. Specialties: FDA and HHS policy, Capitol Hill, drug regulation and approvals.
John Carroll Endpoints News
Editor and founder of Endpoints News with decades covering biopharma; a leading voice on industry trends and strategy. Specialties: Biotech/pharma industry, pipelines, dealmaking, executive leadership.
Joseph Chang ICIS Chemical Business
Global Editor of ICIS Chemical Business, overseeing coverage of global chemicals markets and companies. Specialties: Chemical industry business trends, M&A, petrochemicals, macro drivers.
Michelle Fay Cortez Bloomberg News
Senior Editor/Chief Health Care Correspondent at Bloomberg with deep reporting on drugmakers, science, and policy. Specialties: Global health, pharma and biotech, devices, public health trends.
X | Author page
Allison DeAngelis STAT
STAT’s East Coast biotech and venture capital reporter and co-host of The Readout LOUD podcast. Specialties: Biotech startups, venture capital, biopharma financing/dealmaking.
Adam Feuerstein STAT
Senior writer and biotech columnist at STAT known for sharp analysis of clinical data and market-moving news. Specialties: Biotech pipelines and data, FDA decisions, Wall Street/biotech intersection.
Max Gelman Endpoints News
Senior editor at Endpoints News covering the ideas and data driving the biopharma world. Specialties: Biopharma R&D, oncology and immunology, industry trends/features.
Matthew Herper STAT
Senior writer at STAT covering medicine; long-time chronicler of pharma and biotech advances and pitfalls. Specialties: Medicines and medical innovation, pharma leaders, clinical/science translation.
X | LinkedIn | Author page
Lisa Jarvis Bloomberg Opinion
Bloomberg Opinion columnist focused on biotech, health care and the pharmaceutical industry; former C&EN executive editor. Specialties: Biotech and pharmaceutical industry analysis, drug pricing and policy commentary.
X | Author page
Sarah Karlin-Smith The Pink Sheet (Citeline)
Senior writer at The Pink Sheet covering how U.S. policies shape which drugs are developed, approved and paid for. Specialties: FDA/CMMS policy, drug pricing and access, health politics.
X | Author page
Cynthia Koons Bloomberg News
Team leader for U.S. Health at Bloomberg; veteran reporter on drug industry and global health business. Specialties: U.S. pharma/health industry leadership, major drugmakers, market-moving news.
Robert Langreth Bloomberg News
Health reporter at Bloomberg known for authoritative coverage of drug companies, data and clinical outcomes. Specialties: Pharmaceuticals, biotech breakthroughs, obesity and Alzheimer’s drug coverage.
X | Author page
Peter Loftus The Wall Street Journal
Wall Street Journal reporter covering pharmaceuticals and health care; author of The Messenger on Moderna. Specialties: Pharma and medical devices, FDA and vaccines, big-cap drugmakers.
Eric Sagonowsky FiercePharma
Executive editor at FiercePharma leading coverage across the pharmaceutical lifecycle from R&D to commercialization. Specialties: Drug launches and manufacturing, M&A, IP/patent battles, pipelines.
Alex Scott Chemical & Engineering News (C&EN)
Senior editor for Europe at Chemical & Engineering News, covering the business and geopolitics of chemicals. Specialties: European chemicals industry, decarbonization, petrochemicals and policy/economy.
Ed Silverman STAT
STAT Pharmalot columnist and senior writer with decades on the pharma beat, renowned for scoops and incisive analysis. Specialties: Drug pricing and access, FDA enforcement, industry accountability and ethics.
Alex Tullo Chemical & Engineering News (C&EN)
Senior editor at C&EN who covers chemical industry companies, deals and market dynamics. Specialties: Chemicals business and M&A, polymers, petrochemicals and materials.
Email | Phone | Staff page
Joseph Walker The Wall Street Journal
Wall Street Journal reporter covering pharma and biotech, with features on pricing, access and policy implications. Specialties: Pharma/biotech business, pricing and access, PBMs and 340B dynamics.
Julie Steenhuysen Reuters
Health and science correspondent at Reuters who regularly covers vaccines, drug policy and federal health decisions. Specialties: U.S. health and science, vaccines, public-health agencies and policy impacts on medicines.
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.